New Drug Approved for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
from NYT > Health https://ift.tt/MFGJ3z1
via IFTTT
from NYT > Health https://ift.tt/MFGJ3z1
via IFTTT
No comments